AI-Powered scans could spare breast cancer patients from unnecessary surgery

NCT ID NCT06708910

Recruiting now Knowledge-focused Sponsor: Heinrich-Heine University, Duesseldorf Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 28 times

Summary

This study tests whether a special PET/MRI scan, analyzed by artificial intelligence, can accurately tell if HER2-positive breast cancer has been completely eliminated by chemotherapy before surgery. About 460 women will get three scans over their treatment. If successful, this approach could help some women avoid surgery if their cancer is already gone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf
RECRUITING

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Conditions

Explore the condition pages connected to this study.

HER2-POSITIVE BREAST CARCINOMA